Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly

被引:84
作者
Chhatwal, Jasmeer P. [1 ,2 ,3 ]
Schultz, Aaron P. [1 ,2 ,3 ]
Marshall, Gad A. [1 ,2 ,4 ]
Boot, Brendon [1 ,2 ,4 ,5 ]
Gomez-Isla, Teresa [1 ,2 ]
Dumurgier, Julien [2 ,6 ]
LaPoint, Molly [2 ,3 ]
Scherzer, Clemens [1 ,4 ,7 ]
Roe, Allyson D. [2 ]
Hyman, Bradley T. [1 ,2 ]
Sperling, Reisa A. [1 ,2 ,3 ,4 ]
Johnson, Keith A. [1 ,2 ,3 ,4 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Martinos Ctr Biomed Imaging, Charlestown, MA USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Biogen, Cambridge, MA USA
[6] Univ Paris 07, Lariboisiere Hosp, APHP, Memory Ctr, Paris, France
[7] Harvard NeuroDiscovery Ctr, Boston, MA USA
关键词
ALZHEIMERS-DISEASE; PATHOLOGY; MARKERS; DECLINE;
D O I
10.1212/WNL.0000000000003050
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To better understand cross-sectional relationships between CSF and PET measures of tau pathology, we compared regional and global measures of F-18-T807 (AV-1451) PET to CSF protein levels of total tau (t-tau), phosphorylated tau (p-tau), and beta-amyloid 1-42 (A beta 42). Methods: T-tau, p-tau, and A beta 42 levels were assessed using INNOTEST xMAP immunoassays. Linear regression was used to compare regional and global measures of F-18-T807 standardized uptake value ratios (SUVR) to CSF protein levels using data from 31 cognitively unimpaired elderly participants in the Harvard Aging Brain study. Results: After controlling for sex and age, total cortical F-18-T807 binding was significantly correlated with p-tau (partial r = 0.48; p < 0.01) and at trend level with t-tau (partial r = 0.30; p = 0.12). Regional F-18-T807 measures were more strongly correlated with CSF protein levels than the global measure, with both t-tau and p-tau significantly correlated with F-18-T807 SUVR in entorhinal, parahippocampal, and inferior temporal cortical regions (partial r = 0.53-0.73). Peak correlations between CSF and PET measures of tau were similar to those between CSF and PET measures of amyloid burden. Finally, we observed significantly higher temporal T807 SUVR in individuals with high amyloid burden. Conclusions: These data support the link between F-18-T807 PET and CSF measures of tau pathology. In these cognitively normal individuals with F-18-T807 binding largely restricted to the temporal lobe, F-18-T807 SUVR in temporal regions appeared more reflective of CSF t-tau and p-tau than a total cortical measure.
引用
收藏
页码:920 / 926
页数:7
相关论文
共 24 条
  • [11] Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
    Marquie, Marta
    Normandin, Marc D.
    Vanderburg, Charles R.
    Costantino, Isabel M.
    Bien, Elizabeth A.
    Rycyna, Lisa G.
    Klunk, William E.
    Mathis, Chester A.
    Ikonomovic, Milos D.
    Debnath, Manik L.
    Vasdev, Neil
    Dickerson, Bradford C.
    Gomperts, Stephen N.
    Growdon, John H.
    Johnson, Keith A.
    Frosch, Matthew P.
    Hyman, Bradley T.
    Gomez-Isla, Teresa
    [J]. ANNALS OF NEUROLOGY, 2015, 78 (05) : 787 - 800
  • [12] Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
    Mormino, Elizabeth C.
    Betensky, Rebecca A.
    Hedden, Trey
    Schultz, Aaron P.
    Amariglio, Rebecca E.
    Rentz, Dorene M.
    Johnson, Keith A.
    Sperling, Reisa A.
    [J]. JAMA NEUROLOGY, 2014, 71 (11) : 1379 - 1385
  • [13] Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease
    Mormino, Elizabeth C.
    Betensky, Rebecca A.
    Hedden, Trey
    Schultz, Aaron P.
    Ward, Andrew
    Huijbers, Willem
    Rentz, Dorene M.
    Johnson, Keith A.
    Sperling, Reisa A.
    [J]. NEUROLOGY, 2014, 82 (20) : 1760 - 1767
  • [14] THE CLINICAL DEMENTIA RATING (CDR) - CURRENT VERSION AND SCORING RULES
    MORRIS, JC
    [J]. NEUROLOGY, 1993, 43 (11) : 2412 - 2414
  • [15] Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
    Nelson, Peter T.
    Alafuzoff, Irina
    Bigio, Eileen H.
    Bouras, Constantin
    Braak, Heiko
    Cairns, Nigel J.
    Castellani, Rudolph J.
    Crain, Barbara J.
    Davies, Peter
    Del Tredici, Kelly
    Duyckaerts, Charles
    Frosch, Matthew P.
    Haroutunian, Vahram
    Hof, Patrick R.
    Hulette, Christine M.
    Hyman, Bradley T.
    Iwatsubo, Takeshi
    Jellinger, Kurt A.
    Jicha, Gregory A.
    Koevari, Enikoe
    Kukull, Walter A.
    Leverenz, James B.
    Love, Seth
    Mackenzie, Ian R.
    Mann, David M.
    Masliah, Eliezer
    McKee, Ann C.
    Montine, Thomas J.
    Morris, John C.
    Schneider, Julie A.
    Sonnen, Joshua A.
    Thal, Dietmar R.
    Trojanowski, John Q.
    Troncoso, Juan C.
    Wisniewski, Thomas
    Woltjer, Randall L.
    Beach, Thomas G.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (05) : 362 - 381
  • [16] Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
    Okamura, Nobuyuki
    Furumoto, Shozo
    Harada, Ryuichi
    Tago, Tetsuro
    Yoshikawa, Takeo
    Fodero-Tavoletti, Michelle
    Mulligan, Rachel S.
    Villemagne, Victor L.
    Akatsu, Hiroyasu
    Yamamoto, Takayuki
    Arai, Hiroyuki
    Iwata, Ren
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) : 1420 - 1427
  • [17] Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
    Roe, Catherine M.
    Fagan, Anne M.
    Grant, Elizabeth A.
    Hassenstab, Jason
    Moulder, Krista L.
    Dreyfus, Denise Maue
    Sutphen, Courtney L.
    Benzinger, Tammie L. S.
    Mintun, Mark A.
    Holtzman, David M.
    Morris, John C.
    [J]. NEUROLOGY, 2013, 80 (19) : 1784 - 1791
  • [18] Amyloid β(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
    Schoonenboom, NSM
    Pijnenburg, YAL
    Mulder, C
    Rosso, SM
    Van Elk, EJ
    Van Kamp, GJ
    Van Swieten, JC
    Scheltens, P
    [J]. NEUROLOGY, 2004, 62 (09) : 1580 - 1584
  • [19] Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
    Shaw, Leslie M.
    Vanderstichele, Hugo
    Knapik-Czajka, Malgorzata
    Figurski, Michal
    Coart, Els
    Blennow, Kaj
    Soares, Holly
    Simon, Adam J.
    Lewczuk, Piotr
    Dean, Robert A.
    Siemers, Eric
    Potter, William
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    [J]. ACTA NEUROPATHOLOGICA, 2011, 121 (05) : 597 - 609
  • [20] A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
    Shoup, Timothy M.
    Yokell, Daniel L.
    Rice, Peter A.
    Jackson, Raul N.
    Livni, Eli
    Johnson, Keith A.
    Brady, Thomas J.
    Vasdev, Neil
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (14) : 736 - 740